Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effects of socio-economic and environmental factors on Korean suicidal ideation: A Bayesian multilevel analysis.

Public health·2025
Same author

Correction to: A pharmacogenomic study on the pharmacokinetics of tacrolimus in healthy subjects using the DMET<sup>TM</sup> Plus platform.

The pharmacogenomics journal·2024
Same author

Tick-borne pathogens isolated from ticks, rodents, and a shrew in Gangwon and Gyeonggi provinces in the Republic of Korea.

Tropical biomedicine·2024
Same author

Improved survival in COVID-19 related sepsis and ARDS treated with a unique "triple therapy" including therapeutic plasma exchange: A single center retrospective analysis.

Journal of clinical apheresis·2024
Same author

CRISPR-Cas9 and beyond: identifying target genes for developing disease-resistant plants.

Plant biology (Stuttgart, Germany)·2024
Same author

Mortality Risk Factors in Pediatric Onco-Critical Care Patients and Machine Learning Derived Early Onco-Critical Care Phenotypes in a Retrospective Cohort.

Critical care explorations·2023
Same journal

Computational Study of ADME-TOx from Selected Phytocompounds of Solanum tuberosum and Cucumis sativus.

Current medicinal chemistry·2026
Same journal

QSAR-Based Strategies for Selective-HDAC6 Inhibitor Development: A Detailed Review.

Current medicinal chemistry·2026
Same journal

Breaking New Ground in Oncology: FDA Acceptance of Vepdegestrant NDA Marks a Milestone for PROTAC Therapies in Breast Cancer.

Current medicinal chemistry·2026
Same journal

Knockdown of circFGFR2 inhibits prostate cancer cell metastasis and proliferation by targeting miR-221-5p/ SMUG1 pathway.....

Current medicinal chemistry·2026
Same journal

LncRNA signature associated with amino acid metabolism: A novel prognostic tool for Clear Cell Renal Cell Carcinoma.

Current medicinal chemistry·2026
Same journal

HRI Kinase Modulation by BTdCPU as a Therapeutic Strategy for Bortezomib Resistance in Prostate Cancer.

Current medicinal chemistry·2026
See all related articles

Related Experiment Video

Updated: May 27, 2026

In vitro Quantitative Imaging Assay for Phagocytosis of Dead Neuroblastoma Cells by iPSC-Macrophages
09:48

In vitro Quantitative Imaging Assay for Phagocytosis of Dead Neuroblastoma Cells by iPSC-Macrophages

Published on: February 14, 2021

Immunophilin dysfunction and neuropathology.

H J Park1, J A Rosado, P C Redondo

  • 1Department of Urology, Kangbuk Samsung Hospital, Sungkyunkwan University, 108 Pyung-Dong, Jongro-Gu, Seoul, Korea.

Current Medicinal Chemistry
|November 18, 2011
PubMed
Summary
This summary is machine-generated.

Immunosuppressants like FK506 show promise in promoting axon regeneration and neurological recovery for nervous system damage and neurodegenerative diseases. Further research aims to develop safer, neuroprotective neuroimmunophilin ligands (NILs).

More Related Videos

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration
07:46

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration

Published on: June 18, 2018

System for Focal, Closed-System Central Nervous System Injury
04:02

System for Focal, Closed-System Central Nervous System Injury

Published on: November 29, 2024

Related Experiment Videos

Last Updated: May 27, 2026

In vitro Quantitative Imaging Assay for Phagocytosis of Dead Neuroblastoma Cells by iPSC-Macrophages
09:48

In vitro Quantitative Imaging Assay for Phagocytosis of Dead Neuroblastoma Cells by iPSC-Macrophages

Published on: February 14, 2021

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration
07:46

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration

Published on: June 18, 2018

System for Focal, Closed-System Central Nervous System Injury
04:02

System for Focal, Closed-System Central Nervous System Injury

Published on: November 29, 2024

Area of Science:

  • Neuroscience
  • Immunology
  • Regenerative Medicine

Background:

  • Nervous system damage from trauma or neurodegenerative diseases often leads to unsatisfactory functional recovery.
  • Current treatments struggle to prevent neuronal death, synaptic loss, and promote axon extension, especially in the central nervous system (CNS).
  • Effective strategies for neural repair remain limited, particularly for CNS lesions.

Purpose of the Study:

  • To review the emerging clinical role of immunosuppressants in treating nerve damage and neurodegenerative conditions.
  • To explore the potential of neuroimmunophilin ligands (NILs) in promoting axon regeneration and neurological recovery.
  • To assess the efficacy and limitations of immunosuppressants in various neurological injury models.

Main Methods:

  • Review of studies investigating immunosuppressants, specifically FK506 and other NILs.
  • Analysis of animal models for Parkinson's disease, dementia, and surgical nerve damage.
  • Consideration of clinical data on immunosuppressant treatment for nerve surgery and trauma.

Main Results:

  • Immunosuppressants, such as FK506, demonstrate significant potential in enhancing axon regeneration and neurological recovery.
  • NILs have shown neurotrophic effects, inducing nerve sprouting and preventing damage in preclinical models.
  • Studies indicate potential benefits in conditions like neurogenic erectile dysfunction.

Conclusions:

  • Immunosuppressants and NILs represent a promising therapeutic avenue for neurological repair and treating neurodegenerative diseases.
  • Further development is needed to identify NILs with potent neuroprotective actions and minimal immunological side effects.
  • These agents offer hope for improved outcomes in nerve surgery and managing CNS injuries.